Actos Lawsuit News: $2.4B Settlement Resolves Cancer Allegations

Share Article

Attorneys from The Onder Law Firm handling national Actos lawsuits for Americans making bladder cancer claims report that a settlement has been reached in approximately 9,000 pending lawsuits in U.S. District Court.

James G. Onder

Attorneys providing national Actos lawsuit representation report that a settlement has been reached to resolve approximately 9,000 bladder cancer claims filed against the drug’s maker, Takeda Pharmaceuticals, according to court documents. The cases were consolidated in U.S. District Court in the western district of Louisiana as a multidistrict litigation (MDL), where they have been underway since 2013.

According to court documents, Takeda did not admit liability in the case. However, each claimant can expect an average settlement of over $265,000, adjusted based on the particulars of their case, according to court documents. Actos lawsuits included personal injury claims filed by persons who developed bladder cancer after using Actos, as well as wrongful death claims filed by family members of persons who died of bladder cancer and had a history of using Actos, according to court documents.

All the claims in the multidistrict litigation shared common facts, including claims that Takeda Pharmaceuticals knew of the alleged connection between Actos and bladder cancer since early animal safety testing revealed it in the 1990s, before the drug was released in the United States in 1999, yet did not adequately warn consumers, according to court documents. A bladder cancer warning was not added to the Actos label until 2011, when the FDA** made this addition a requirement, according to court documents.

According to court documents, Actos has yielded more than $16 billion in sales since it was first released in the United States in 1999.

Attorneys handling national Actos lawsuits for the Onder Law Firm are still accepting new claims from persons and the family members of persons who developed bladder cancer and have a history of taking Actos. Lawyers are investigating these inquiries for possible Actos lawsuits. The Onder Law Firm is recognized for its achievements in product and consumer safety litigation, with a strong track record of winning meaningful settlements for clients. The firm is nationally-renowned for its work on window blind strangulation, and has notable expertise in fighting on behalf of individuals against powerful, multinational pharmaceutical companies. Individuals and the family members of individuals who were diagnosed with bladder cancer and have a history of taking Actos are eligible for a no-cost, no-obligation Actos lawsuit case review, and may contact the firm through its Actos Lawsuit website.

The Onder Law Firm also welcomes Actos lawsuit inquiries from other law firms, either to handle these inquiries or work as co-counsel.

About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firm’s Actos attorneys provide information to the public at ActosBladderCancerLawsuits.com.

*Actos (Pioglitazone) Products Liability Litigation, 11-md-02299, U.S. District Court, Western District of Louisiana
**”FDA Drug Safety Communication: Update to ongoing safety review of Actos and increased risk of bladder cancer”, 6/15/11, fda.gov/Drugs/DrugSafety/ucm259150.htm

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Gudeman
Gudeman Group
+1 314-614-8709
Email >
Follow us on
Visit website